Immunohistochemical investigations and introduction of new therapeutic strategies in scleromyxoedema: Case report

BMC Dermatology

Volumn 4, Issue , 2004, Pages

  Breuckmann, Frank ^a   Freitag, Marcus ^a   Rotterdam, Sebastian ^a   Stuecker, Markus ^a   Altmeyer, Peter ^a   Kreuter, Alexander ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID GLYCOSAMINOGLYCAN; FOLIC ACID; IMMUNOGLOBULIN KAPPA CHAIN; KI 67 ANTIGEN; PARAPROTEIN; PROTEIN ANTIBODY; TRYPTASE; GLYCOSAMINOGLYCAN; METHOTREXATE;

ADULT; ARM DISEASE; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CAUCASIAN; CELL PROLIFERATION; CLINICAL FEATURE; DATA ANALYSIS; ERYTHEMA; FEMALE; FIBROBLAST; FOREHEAD; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEG DISEASE; LYMPHOCYTIC INFILTRATION; MONOCLONAL IMMUNOGLOBULINEMIA; MORPHOLOGY; PHOTOTHERAPY; PLASMACYTOMA; PROTEIN EXPRESSION; RADIATION DOSE; RASH; SCLEROMYXEDEMA; SHOULDER; SKIN COLOR; SYMPTOMATOLOGY; TREATMENT PLANNING; ULTRAVIOLET A RADIATION; CHEMISTRY; CHRONIC DISEASE; LOCALIZED SCLERODERMA; MYXEDEMA; PATHOLOGY; SKIN;

ADULT; CHRONIC DISEASE; ERYTHEMA; FEMALE; FOLIC ACID; GLYCOSAMINOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; METHOTREXATE; MYXEDEMA; PHOTOTHERAPY; SCLERODERMA, LOCALIZED; SKIN;

EID: 10444267200     PISSN: 14715945     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-5945-4-12     Document Type: Article

References (25)

1. Pomann JJ, Rudner E: Scleromyxedema revisited. Int J Dermatol 2003, 42:31-35.
2. Ayala F, Balato N, Ceparano S, Castello G: Immunochemical characterization of the abnormal paraprotein in a case of scleromyxedema. Clin Exp Dermatol 1984, 9:351-357.
3. Webster GF, Matsuoka LY, Burchmore D: The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis). J Am Acad Dermatol 1993, 28:105-108.
4. Morris-Jones R, Staughton RC, Walker M, Sheridan DJ, Rajappan K, Leonard J, Hardman C: Lichen myxoedematosus with associated cardiac abnormalities. Br J Dermatol 2001, 144:594-596.
5. Takama H, Ohashi M, Iwata H: Scleromyxedema - studies on glycosaminoglycans (authors transl). Nippon Hifuka Gakkad 1976, 86:417-425.
6. Rudner EJ, Mehregan A, Pinkus H: Scleromyxedema: a variant of lichen myxedematosus. Arch Dermatol 1966, 93:3-12.
7. Rongioletti F, Rebora A: Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001, 44:273-281.
8. Hill TG, Crawford JN, Rogers CC: Successful management of lichen myxoedematosus. Arch Dermatol 1976, 112:67-69.
9. McCarthy JT, Osserman E, Lombardo PC, Takatsuki K: An abnormal serum globulin in lichen myxedematosus. Arch Dermatol 1964, 89:446-450.
10. Rowell NR, Waite A, Scott DG: Multiple serum protein abnormalities in lichen myxoedematosus. Br J Dermatol 1969, 81:753-758.
11. Stücker M, Nowack U, Röchling A, Bacharach-Buhles M, el Gammal S, Panz B, Altmeyer P: Sweat gland proliferations in scleromyxedema. Arch J Dermatopath 1999, 21:259-264.
12. Howsden SM, Herndon JH Jr, Freeman RG: Lichen myxoedematosus. A dermal infiltrative disorder responsive to cyclophosphamide therapy. Arch Dermatol 1975, 111: 325-1330.
13. Rongioletti F, Hazini A, Rebora A: Coma associated with scleromyxoedema and interferon alfa therapy. Full recovery after steroids and cyclophosphamide combined with plasmapheresis. Br J Dermatol 2001, 144:1283-1284.
14. Harris RB, Perry HO, Kyle RA, Winkelmann RK: Treatment of scleromyxedema with melphalan. Arch Dermatol 1979, 115: 95-299.
15. Koeppel MC, Aquilina C, Terrier G, Sayag J: Electron-beam therapy in Arndt-Gottron's scleromyxoedema. Br J Dermatol 1993, 129:733-735.
16. Krasagakis K, Zouboulis CC, Owsianowski , Ramaker J, Trautmann C, Tebbe B, Orfanos CE: Remission of scleromyxoedema following treatment with extracorporeal photopheresis. Br J Dermatol 1996, 135:463-466.
17. Farr PM, Ive FA: PUVA treatment of scleromyxoedema. Br J Dermatol 1984, 110:347-350.
18. Adachi Y, Iba S, Horio T: Successful treatment of lichen myxoedematosus with PUVA photochemotherapy. Photodermatol Photoimmunol Photomed 2000, 16:229-231.
19. Terheyden P, Becker JC, Lurz C, Kahaly GJ, Bröcker EB: Treatment of scleromyxoedema with hydroxychloroquine. JDDG 2003, 1:30-35.
20. Kulczycki A, Nelson M, Eisen A, Heffeman M: Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Br J Dermatol 2003, 149:1276-1281.
21. Burgess WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem 1989, 58: 75-606.
22. Sawada H, Isogai Z, Morita A: Altered decorin expression of systemic sclerosis by UVA1 (340-400 nm) phototherapy: Immunohistochemical analysis of 3 cases. BMC Dermatol 2003, 3:2.
23. Abd El-Aaal H, Salem SZ, Salem A: Lichen myxedematosus: histochemical study. Dermatologica 1981, 162:273-276.
24. Jablonska S, Blaszcyk M: New treatments in scleroderma: dermatologic perspective. JEADV 2002, 16:526-528.
25. Dawe RS: Ultraviolet A1 phototherapy. Br J Dermatol 2003, 148:626-637.